These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23964070)

  • 1. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
    Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from mouse models of high-fat diet-induced NAFLD.
    Nakamura A; Terauchi Y
    Int J Mol Sci; 2013 Oct; 14(11):21240-57. PubMed ID: 24284392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
    Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
    Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
    Kirovski G; Dorn C; Huber H; Moleda L; Niessen C; Wobser H; Schacherer D; Buechler C; Wiest R; Hellerbrand C
    Exp Mol Pathol; 2011 Dec; 91(3):780-3. PubMed ID: 21855538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet.
    Okada H; Takabatake R; Honda M; Takegoshi K; Yamashita T; Nakamura M; Shirasaki T; Sakai Y; Shimakami T; Nagata N; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Jun; 8(25):39978-39993. PubMed ID: 28591717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
    Scorletti E; Byrne CD
    Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
    Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
    Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin increases hepatic leptin receptor and decreases steatosis in mice.
    Tang X; Li J; Xiang W; Cui Y; Xie B; Wang X; Xu Z; Gan L
    J Endocrinol; 2016 Aug; 230(2):227-37. PubMed ID: 27288055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model.
    Aparicio-Vergara M; Hommelberg PP; Schreurs M; Gruben N; Stienstra R; Shiri-Sverdlov R; Kloosterhuis NJ; de Bruin A; van de Sluis B; Koonen DP; Hofker MH
    Hepatology; 2013 Feb; 57(2):566-76. PubMed ID: 22941955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    de Oliveira S; Houseright RA; Graves AL; Golenberg N; Korte BG; Miskolci V; Huttenlocher A
    J Hepatol; 2019 Apr; 70(4):710-721. PubMed ID: 30572006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective adipose tissue development associated with hepatomegaly in cathepsin E-deficient mice fed a high-fat diet.
    Kadowaki T; Kido MA; Hatakeyama J; Okamoto K; Tsukuba T; Yamamoto K
    Biochem Biophys Res Commun; 2014 Mar; 446(1):212-7. PubMed ID: 24583126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.